Serum levels of different forms of soluble CD38 antigen in burned patients

Burns

Volumn 30, Issue 6, 2004, Pages 552-556

  Lebedev, M Ju ^a   Egorova, N I ^b   Sholkina, M N ^a   Vilkov, S A ^a   Baryshnikov, A Ju ^c   Novikov, V V ^b  

^a PRIVOLZHSKY RESEARCH MEDICAL UNIVERSITY   (Russian Federation)

^b LOBACHEVSKY STATE UNIVERSITY OF NIZHNY NOVGOROD   (Russian Federation)

^c N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

Author keywords

Activation antigens; Burn; Lymphocyte; mCD38; sCD38

Indexed keywords

CD38 ANTIGEN;

ADULT; ANTIGEN EXPRESSION; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; BURN; BURN SHOCK; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; LYMPHOCYTE; LYMPHOCYTE ACTIVATION; SOLUBILITY; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADP-RIBOSYL CYCLASE; ADULT; ANTIGENS, CD; ANTIGENS, CD38; BURNS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MEMBRANE GLYCOPROTEINS; SOLUBILITY; TIME FACTORS;

EID: 4143085213     PISSN: 03054179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.burns.2004.01.029     Document Type: Article

References (28)

1. Till G.O. Cellular and humoral defense systems and inflammatory mechanisms in thermal injury. Clin Lab Med. 3(4):1983;801-815
2. Alessio M., Roggero S., Funaro A., De Monte L.B., Peruzzi L., Geuna M., et al. CD38 molecule: structural and biochemical analysis on human T lymphocytes, thymocytes, and plasma cells. J. Immunol. 145:1990;878-884
3. Malavasi F., Funaro A., Roggero S., Horenstein A., Calosso L., Mehta K., et al. Human CD38: a glycoprotein in search of a function. Immunol Today. 15(3):1994;95-97
4. Deaglio S, Mehta K, Malavasi F. Human CD38: a (r)evolutionary story of enzymes and receptors. Leuk Res 2001;(25):1-12.
5. Funaro A., Spagnoli G.C., Ausiello C.M. Involvement of the multilineage CD38 molecule in a unique pathway of cell activation and proliferation. J Immunol. 145:1990;2390-2396
6. Inoue S., Kontani K., Tsujimoto N., Kanda Y., Hosoda N., Hoshino S., et al. Protein-tyrosine phosphorylation by IgG1 subclass CD38 monoclonal antibodies is mediated through stimulation of the FcgII receptors in human myeloid cell lines. J Immunol. 159:1997;5226-5232
7. Funaro A., Morra M., Calosso L., Zini M.G., Ausiello C.M., Malavasi F., et al. Role of the human CD38 molecule in B cell activation and proliferation. Tissue Antigens. 49:1997;7-15
8. Zubiaur M., Izquierdo M., Terhorst C., Malavasi F., Sancho J. CD38 ligation results in activation of the Raf-1:mitogen-activated protein kinase and the CD3-zeta:zeta-associated protein-70 signaling pathways in Jurkat T lymphocytes. J Immunol. 159:1997;193-205
9. + lymphocytes. Role of the human CD38 molecule. J Immunol. 153:1994;952-959
10. Deaglio S., Dianzani U., Horenstein A.L., Fernandez J.E., van Kooten C., Bragardo M., et al. Human CD38 ligand. A 120-kDa protein predominantly expressed on endothelial cells. J Immunol. 156:1996;727-734
11. Newman P.J. Switched at birth: a new family for PECAM-1. J Clin Invest. 103:1999;5-9
12. Deaglio S., Morra M., Mallone R., Ausiello C.M., Prager E., Garbarino G., et al. Human CD38 (ADP-ribosyl cyclase) is a counter-receptor of CD31, an Ig superfamily member. J Immunol. 160:1998;395-402
13. Funaro A., Horenstein A.L., Calosso L., Morra M., Tarocco R.P., Franco L., et al. Identification and characterization of an active soluble form of human CD38 in normal and pathological fluids. Int Immunol. 8(11):1996;1643-1650
14. Mallone R., Ferrua S., Morra M., Zocchi E., Mehta K., Notarangelo L.D., et al. Characterization of a CD38-like 78-kilodalton soluble protein released from B cell lines derived from patients with X-linked agammaglobulinemia. J Clin Invest. 101(12):1998;2821-2830
15. Ptitsina Yu.S., Kopnina E.O., Matveeva E.M., Matveeva E.M., Nosov N.N., Martynova T.G., et al. The study of soluble CD38 antigen level at viral infections. Russ J Immunol. 4:1999;153
16. Ptitsina Yu.S., Matveeva E.M., Kopnina E.O., Martynova T.G., Nosov N.N., Baryshnikov A.Ju., et al. Increased level of soluble CD38 antigen in sera of HIV-infected persons. Russ J HIV/AIDS. 3(1):1999;166-167
17. Horenstein A.L., Stockinger H., Imhof B.A., Malavasi F. CD38 binding to human myeloid cells is mediated by mouse and human CD31A. Biochem J. 330:1998;1129-1135
18. Deaglio S, Mallone R, Baj G, Arnulfo A, Dianzani U, Malavasi F, et al. CD38:CD31, a receptor:ligand system ruling adhesion and signaling in human leukocytes. In: Mehta K, Malavasi F, editors. Human CD38 and related molecules. Basel: Kargel; 2000. p. 99-116.
19. Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 × g. Scand J Clin Lab Invest. 97:1968;77-89
20. Lebedev M.Ju., Sholkina M.N., Utkina T.M., Vilkov S.A., Golubcova N.V., Baryshnikov A.Ju., et al. Immunophenotype of peripheral blood lymphocytes in burn patients. Russ J Immunol. 6(1):2001;47-54
21. Wood J.J., O'Mahony J.B., Rodrick M.L., Mannick J.A. Immature T lymphocytes after injury characterized by morphology and phenotypic markers. Ann Surg. 206(5):1987;564-571
22. Lebedev M.Ju., Ptitsina Ju.S., Vilkov S.A., Korablev S.B., Novikov V.V. Membrane and soluble forms of Fas (CD95) in peripheral blood lymphocytes and in serum from burns patients. Burn. 27(7):2001;669-673
23. Lebedev M.Ju., Krizhanova M.A., Vilkov S.A., Sholkina M.N., Vyasmina E.S., Baryshnikov A.Ju., et al. Peripheral blood lymphocytes immunophenotype and serum concentration of soluble HLA class I in burn patients. Burn. 29(2):2003;123-128
24. + cells in HIV-1-infected and high-risk individuals. Clin Immunol Immunopathol. 73:1994;252-260
25. Posseckert G., Dummer A., Nestle F., Piezsch C., Burg G. Physiological relevance of shedding IL-2 receptor alpha chian (sIL-2R) Schweiz med wochenschr. 121(40):1991;62-65
26. Jun C.D., Carman C.V., Redick S.D., Shimaoka M., Erickson H.P., Springer T.A., et al. Ultrastructure and function of dimeric, soluble intercellular adhesion molecule-1 (ICAM-1). J Biol Chem. 276(31):2001;29019-29027
27. Vakkalanka R.K., Woo C., Kirou K.A., Koshy M., Berger D., Crow M.K., et al. Elevated levels and functional capacity of soluble CD40 ligand in systemic lupus erythematosus sera. Arthritis Rheum. 42:1999;871-881
28. Mozingo DW, Mason AD. Hypophosphatetia. In: Herndon DN, editor. Total burn care. London: Saunders; 1996. p. 259-64.